

2,3 This evolved further in the Kanso 2 Sound Processor, with the addition of a built-in rechargeable battery designed for all-day hearing 4 paired with a new auto-on feature designed to simplify the daily routine. Natasha McDougald: Our first generation Kanso® Sound Processor taught us that patients and clinicians valued a comfortable, simple design that was easy to use, combined with smart features that positively impacted overall hearing performance. 1ĪudiologyOnline: What did recipients say about the Kanso 2 Sound Processor?
#Kanso 2 price how to#
Natasha McDougald: We had a wide range of patients participating, from small children ranging to adults over 80 years old! 78% of our participants were upgrading to the Kanso 2 Sound Processor, while 22% were new cochlear implant activations – learning how to hear with their device. A cohort containing both newly activated patients hearing with a cochlear implant for the first time and veteran recipients upgrading allowed us the understanding how this unique processor fits in their daily lives.ĪudiologyOnline: What were the demographics of the patients who participated? With 85 patients being fit with the Kanso 2 Sound Processor globally, we were able to collect valuable insights into how they wore their device, daily accessory usage and clinical fitting trends. With that in mind, we completed a large-scale controlled market release of the Kanso 2 Sound Processor to better understand how our patients would use it, and how our professionals would fit it. Natasha McDougald: At Cochlear, innovation is directly inspired by people: our recipients who use hearing to connect to life and our professionals who help them achieve this goal. + Finally, this approval brought our second generation off-the-ear (OTE) sound processor to the market, the Cochlear™ Nucleus® Kanso® 2 Sound Processor.ĪudiologyOnline: After approval, what were the next steps to commercializing the Kanso 2 Sound Processor? Our Nucleus® 7 Sound Processor was extended to our very first implant recipients with the Nucleus 22 implant – allowing them for the first time to directly stream music, entertainment and ZOOM calls from their smartphone. It also introduced our next generation fitting software, Cochlear™ Custom Sound® Pro, designed for clinicians by clinicians, which brings the patient to the center of the fitting process. Natasha McDougald: This past July, Cochlear received a suite of approvals from the FDA encompassing the entire Cochlear™ Nucleus® Implant system – from inside to out! This included a new electrode in the Nucleus® Electrode portfolio, the Slim 20 (CI624), optimized for insertion to 20 mm.
